Terms: = Kidney tumors AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Treatment
177 results:
1. Combination immune checkpoint and targeted protein kinase inhibitors for the treatment of renal cell carcinomas.
Roskoski R
Pharmacol Res; 2024 May; 203():107181. PubMed ID: 38614375
[TBL] [Abstract] [Full Text] [Related]
2. Nilotinib in kit-driven advanced melanoma: Results from the phase II single-arm NICAM trial.
Larkin J; Marais R; Porta N; Gonzalez de Castro D; Parsons L; Messiou C; Stamp G; Thompson L; Edmonds K; Sarker S; Banerji J; Lorigan P; Evans TRJ; Corrie P; Marshall E; Middleton MR; Nathan P; Nicholson S; Ottensmeier C; Plummer R; Bliss J; Valpione S; Turajlic S
Cell Rep Med; 2024 Mar; 5(3):101435. PubMed ID: 38417447
[TBL] [Abstract] [Full Text] [Related]
3. [A Case of Recurrent Gastric GIST Who Survived for Long after Laparoscopic Resection and Imatinib Therapy].
Yabe N; Takenoya T; Oto I; Harada Y; Kondo A; Ogiso M; Maeda H; Asada Y; Sako H; Yoshikawa T; Osumi K; Kamiya N; Sotome K; Ishii Y; Watanabe M
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1718-1720. PubMed ID: 38303184
[TBL] [Abstract] [Full Text] [Related]
4. Hsa_circ_0086414/transducer of ERBB2 (TOB2) axis-driven lipid elimination and tumor suppression in clear cell renal cell cancer via perilipin 3.
Meng X; Li W; Yu T; Lu F; Wang C; Yuan H; Yang W; Dong W; Xiao W; Zhang X
Int J Biol Macromol; 2024 Mar; 261(Pt 1):129636. PubMed ID: 38272402
[TBL] [Abstract] [Full Text] [Related]
5. Identification of Crotonylation Metabolism Signature Predicting Overall Survival for Clear Cell Renal Cell Carcinoma.
Zheng J; Liu Y; Wei K; Shi J; Li L; Jiang X; Tao L
Int J Clin Pract; 2023; 2023():5558034. PubMed ID: 38058677
[TBL] [Abstract] [Full Text] [Related]
6. Celastrol enhances TRAIL‑R2‑mediated apoptosis and cytotoxicity in human renal cell carcinoma cells in caspase‑dependent manner.
Bao Y; Wu X; Kanematsu A; Kita Y; Kobayashi T; Kakehi Y; Yamamoto S
Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37997857
[TBL] [Abstract] [Full Text] [Related]
7. Baicalein improves the chemoresistance of ovarian cancer through regulation of CirSLC7A6.
Li S; Yi Z; Li M; Zhu Z
J Ovarian Res; 2023 Nov; 16(1):212. PubMed ID: 37940982
[TBL] [Abstract] [Full Text] [Related]
8. [Mechanism of nuclear protein 1 in the resistance to axitinib in clear cell renal cell carcinoma].
Liu YC; Wu ZL; Ge LY; DU T; Wu YQ; Song YM; Liu C; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):781-792. PubMed ID: 37807730
[TBL] [Abstract] [Full Text] [Related]
9. A novel drug specific mRNA biomarker predictor for selection of patients responding to dovitinib treatment of advanced renal cell carcinoma and other solid tumors.
Knudsen S; Hansen A; Foegh M; Petersen S; Mekonnen H; Jia L; Shah P; Martin V; Frykman G; Pili R
PLoS One; 2023; 18(8):e0290681. PubMed ID: 37647320
[TBL] [Abstract] [Full Text] [Related]
10. HGF-Based CAR-T Cells Target Hepatocellular Carcinoma Cells That Express High Levels of c-Met.
Ma H; Wei W; Liang D; Xu X; Yang D; Wang Q; Wang Y; Wei Q; Sun B; Zhao X
Immunol Invest; 2023 Nov; 52(6):735-748. PubMed ID: 37409941
[TBL] [Abstract] [Full Text] [Related]
11. GPD1L inhibits renal cell carcinoma progression by regulating PINK1/Parkin-mediated mitophagy.
Liu T; Zhu H; Ge M; Pan Z; Zeng Y; Leng Y; Yang K; Cheng F
J Cell Mol Med; 2023 Aug; 27(16):2328-2339. PubMed ID: 37382962
[TBL] [Abstract] [Full Text] [Related]
12. LINC01480 as a Prognostic Biomarker Associated With Proliferation, Migration, and Invasion of Clear Cell Renal Cell Carcinoma.
Ma Y; Wu C; Deng S
Anticancer Res; 2023 Jul; 43(7):3037-3046. PubMed ID: 37351956
[TBL] [Abstract] [Full Text] [Related]
13. Computational docking and
Otifi HM; Alshyarba M; Fayi MA; Dera AA; Rajagopalan P
Oncol Res; 2021; 29(3):217-227. PubMed ID: 37304673
[TBL] [Abstract] [Full Text] [Related]
14. A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinoma.
Ness DB; Pooler DB; Ades S; Highhouse BJ; Labrie BM; Zhou J; Gui J; Lewis LD; Ernstoff MS
Cancer Med; 2023 Jun; 12(12):13100-13110. PubMed ID: 37148554
[TBL] [Abstract] [Full Text] [Related]
15. Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers.
Jin J; Xie Y; Zhang JS; Wang JQ; Dai SJ; He WF; Li SY; Ashby CR; Chen ZS; He Q
Drug Resist Updat; 2023 Mar; 67():100929. PubMed ID: 36739809
[TBL] [Abstract] [Full Text] [Related]
16. 10-Gingerol Enhances the Effect of Taxol in Triple-Negative Breast Cancer via Targeting ADRB2 Signaling.
Liang Y; Wu G; Luo T; Xie H; Zuo Q; Huang P; Li H; Chen L; Lu H; Chen Q
Drug Des Devel Ther; 2023; 17():129-142. PubMed ID: 36712945
[TBL] [Abstract] [Full Text] [Related]
17. ENO2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune microenvironment.
Chen WJ; Yang W; Gong M; He Y; Xu D; Chen JX; Chen WJ; Li WY; Wang YQ; Dong KQ; Song X; Pan XW; Cui XG
Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36562383
[TBL] [Abstract] [Full Text] [Related]
18. Knockdown of hsa_circ_0043691 restrains the progression of gastric cancer by decoying miR-1294 to target pre-leukemia transcription factor 3.
Wu J; Gong P; Jiang Z
J Clin Lab Anal; 2022 Dec; 36(12):e24733. PubMed ID: 36371782
[TBL] [Abstract] [Full Text] [Related]
19. A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma.
Ligon JA; Sundby RT; Wedekind MF; Arnaldez FI; Del Rivero J; Wiener L; Srinivasan R; Spencer M; Carbonell A; Lei H; Shern J; Steinberg SM; Figg WD; Peer CJ; Zimmerman S; Moraly J; Xu X; Fox S; Chan K; Barbato MI; Andresson T; Taylor N; Pacak K; Killian JK; Dombi E; Linehan WM; Miettinen M; Piekarz R; Helman LJ; Meltzer P; Widemann B; Glod J
Clin Cancer Res; 2023 Jan; 29(2):341-348. PubMed ID: 36302175
[TBL] [Abstract] [Full Text] [Related]
20. Gastrointestinal tumors in transplantation: Two case reports and review of literature.
Stammler R; Anglicheau D; Landi B; Meatchi T; Ragot E; Thervet E; Lazareth H
World J Gastroenterol; 2022 Sep; 28(34):5076-5085. PubMed ID: 36160649
[TBL] [Abstract] [Full Text] [Related]
[Next]
